The bill amends the existing law regarding the prohibition of civil actions related to opioids by certain governmental officers and entities in Michigan. It introduces definitions for various settlements arising from the multidistrict litigation (MDL) concerning opioid-related claims, including settlements with companies such as Allergan, CVS, and Purdue Pharma, among others. These definitions clarify the scope of the settlements and the entities involved, ensuring that the law is precise in its application.

Additionally, the bill specifies the timeline for when political subdivisions are prohibited from commencing or maintaining actions related to the released claims defined in each settlement. For instance, actions related to the distributor settlement and the Janssen settlement are barred after January 1, 2021, while actions related to the Kroger settlement are prohibited after January 1, 2024. The bill establishes a structured timeline for various settlements, culminating in a prohibition on actions related to several settlements after January 1, 2025. This structured approach aims to provide clarity and finality regarding the legal landscape surrounding opioid-related claims in Michigan.

Statutes affected:
Senate Introduced Bill: 691.1672, 691.1673
As Passed by the Senate: 691.1672, 691.1673
As Passed by the House: 691.1672, 691.1673
Senate Enrolled Bill: 691.1672, 691.1673